About PleoPharma, Inc.
PleoPharma is a pharmaceutical company focused on developing treatments for unmet medical needs in the CNS and substance abuse space, particularly addressing Cannabis Use Disorder (CUD) and Cannabis Withdrawal Syndrome (CWS). The company was founded in 2019 by two physicians and has a lead program that has successfully completed Phase 2.
Development of oral prescription medications for substance use disordersResearch and development of treatments for Cannabis Use Disorder (CUD) and Cannabis Withdrawal Syndrome (CWS)Clinical research and medical expertise in CNS and substance abuse therapies
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to PleoPharma, Inc. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.